Display options
Share it on

Neuroepidemiology. 2019;52(3):161-172. doi: 10.1159/000494291. Epub 2019 Jan 22.

Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Neuroepidemiology

Merel C Broers, Carina Bunschoten, Daan Nieboer, Hester F Lingsma, Bart C Jacobs

Affiliations

  1. Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands, [email protected].
  2. Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  3. Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  4. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

PMID: 30669140 PMCID: PMC6518865 DOI: 10.1159/000494291

Abstract

BACKGROUND: Prevalence and incidence rates of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are required to determine the impact of CIDP on society. We aimed to estimate the prevalence and incidence of CIDP worldwide and to determine the effect of diagnostic criteria on prevalence and incidence.

METHOD: A systematic review was conducted for all published incidence and prevalence studies on CIDP until May 18, 2017. Methodological quality was assessed using the Methodological Evaluation of Observational Research checklist. We performed a random effect meta-analysis to estimate pooled prevalence and incidence rates.

RESULTS: Of the 907 studies, 11 were included in the systematic review, 5 in the meta-analysis of incidence (818 cases; 220,513,514 person-years) and 9 in the meta-analysis of prevalence (3,160 cases; 160,765,325 population). These studies had a moderate quality. The pooled crude incidence rate was 0.33 per 100,000 person-years (95% CI 0.21-0.53; I2 = 95.7%) and the pooled prevalence rate was 2.81 per 100,000 (95% CI 1.58-4.39; I2 = 99.1%). Substantial heterogeneity in incidence and prevalence across studies seems to be partly explained by using different diagnostic criteria.

CONCLUSION: These findings provide a starting point to estimate the social burden of CIDP and demonstrate the need to reach consensus on diagnostic criteria for CIDP.

© 2019 The Author(s) Published by S. Karger AG, Basel.

Keywords: Chronic inflammatory demyelinating polyradiculoneuropathy; Incidence; Meta-analysis; Prevalence; Systematic review

References

  1. J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1364-8 - PubMed
  2. Neurology. 2007 May 8;68(19):1622-9 - PubMed
  3. Muscle Nerve. 2011 Jun;43(6):780-94 - PubMed
  4. Neurology. 2010 Aug 31;75(9):818-25 - PubMed
  5. Ann Neurol. 1999 Dec;46(6):910-3 - PubMed
  6. JAMA Neurol. 2017 Oct 1;74(10):1190-1198 - PubMed
  7. N Engl J Med. 2005 Mar 31;352(13):1343-56 - PubMed
  8. Eur Neurol. 2016;75(5-6):263-8 - PubMed
  9. J Diabetes Complications. 2016 Sep-Oct;30(7):1401-7 - PubMed
  10. J Peripher Nerv Syst. 2014 Mar;19(1):2-13 - PubMed
  11. J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1349-53 - PubMed
  12. J Neurol Sci. 2016 Oct 15;369:204-209 - PubMed
  13. Rheumatology (Oxford). 2017 Nov 1;56(11):1945-1961 - PubMed
  14. Eur J Epidemiol. 2016 Jan;31(1):5-20 - PubMed
  15. PLoS One. 2012;7(10):e48078 - PubMed
  16. Muscle Nerve. 2014 Jul;50(1):47-51 - PubMed
  17. J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35 - PubMed
  18. J Orofac Pain. 2013 Spring;27(2):99-110 - PubMed
  19. Eur J Neurol. 2014;21(1):28-33 - PubMed
  20. J Neurol Neurosurg Psychiatry. 1999 May;66(5):677-80 - PubMed
  21. J Neurotrauma. 2018 Dec 19;: - PubMed
  22. Clin Epidemiol. 2014 Jul 30;6:247-55 - PubMed
  23. J Peripher Nerv Syst. 2010 Dec;15(4):326-33 - PubMed
  24. J Neuromuscul Dis. 2017;4(2):127-137 - PubMed
  25. Neurology. 2015 Jan 20;84(3):259-64 - PubMed
  26. Eur J Neurol. 2006 Apr;13(4):326-32 - PubMed
  27. J Oral Rehabil. 2013 Aug;40(8):631-42 - PubMed
  28. J Clin Epidemiol. 2011 Jun;64(6):637-57 - PubMed
  29. Eur J Neurol. 2007 Jun;14(6):603-8 - PubMed
  30. Muscle Nerve. 2014 Jul;50(1):40-6 - PubMed
  31. J Peripher Nerv Syst. 2010 Mar;15(1):1-9 - PubMed
  32. Ann Neurol. 2001 Aug;50(2):195-201 - PubMed
  33. Neurology. 1991 May;41(5):617-8 - PubMed
  34. Neurology. 2003 Apr 1;60(8 Suppl 3):S8-15 - PubMed
  35. Muscle Nerve. 2009 Apr;39(4):432-8 - PubMed
  36. Neurology. 2009 Jul 7;73(1):39-45 - PubMed
  37. Neurology. 1997 Feb;48(2):321-8 - PubMed
  38. Cochrane Database Syst Rev. 2017 Jan 13;1:CD010369 - PubMed
  39. Neuroepidemiology. 2011;36(2):123-33 - PubMed
  40. J Peripher Nerv Syst. 2009 Dec;14(4):310-5 - PubMed
  41. Brain. 1987 Dec;110 ( Pt 6):1617-30 - PubMed
  42. PLoS One. 2013 Jun 19;8(6):e66435 - PubMed
  43. Lancet Neurol. 2010 Apr;9(4):402-12 - PubMed
  44. Mayo Clin Proc. 1975 Nov;50(11):621-37 - PubMed
  45. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1118-1119 - PubMed
  46. Ann Rheum Dis. 2015 Jan;74(1):65-73 - PubMed
  47. Neuromuscul Disord. 2016 Jul;26(7):447-52 - PubMed
  48. Neurology. 2017 Jan 17;88(3):304-313 - PubMed
  49. J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1040-3 - PubMed
  50. Muscle Nerve. 1989 Jun;12(6):435-51 - PubMed
  51. J Neuromuscul Dis. 2015;2(1):73-85 - PubMed
  52. Muscle Nerve. 2001 Mar;24(3):311-24 - PubMed
  53. Lancet. 2016 Aug 13;388(10045):717-27 - PubMed
  54. Nat Rev Neurol. 2011 Nov 22;8(1):48-58 - PubMed
  55. Neurol Res. 2012 Dec;34(10):960-6 - PubMed
  56. Eur J Neurol. 2001 Mar;8(2):157-65 - PubMed
  57. Psychiatry Clin Neurosci. 1995 Jun;49(3):169-74 - PubMed

MeSH terms

Publication Types